A multinational collaboration of researchers found that efavirenz, the key component of the most commonly used HIV cocktail in the
Continue reading »
New drugs are improving survival times for patients with aggressive type of blood cancer, study finds
Survival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the
Continue reading »
Effect of shock wave treatment for erectile dysfunction wanes
(HealthDay)—Low-intensity shock wave treatment is effective for short-term treatment of erectile dysfunction, but its efficacy declines after two years, particularly
Continue reading »
Collaborative model for post-disaster behavioral health recovery may serve as standard
Faculty in LSU Health New Orleans schools of Medicine and Public Health and colleagues report that a collaborative effort to
Continue reading »
New technology helps to improve treatment for NHS patients with depression
A new web-based “feedback” technology which allows therapists to accurately monitor how patients with depression are coping has been found
Continue reading »
Study reveals new therapeutic target for slowing the spread of flu virus
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus
Continue reading »
Allen Institute for Brain Science database release nearly doubles mouse brain cell data
The Allen Institute for Brain Science today announced the release of new data, tools to analyze those data and a
Continue reading »
Human immune ‘trigger’ map paves way for better treatments
A discovery about how human cells are ‘triggered’ to undergo an inflammatory type of cell death could have implications for
Continue reading »
Shared genetics may shape treatment options for certain brain disorders
Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an
Continue reading »
Deep brain stimulation showing promise for patients with mild Alzheimer’s disease over 65
An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue
Continue reading »